Complete publication list on PubMed | Citation metrics on Google Scholars

Research articles (in reverse chronological order)

Nauroy P, Hughes S, Naba A*, and Ruggiero F*. (2018) The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions. Matrix Biology, 65:5-13. [Full Text]

Naba A*#, Pearce OMT*#, Del Rosario A, Ma D, Ding H, Rajeeve V, Cutillas P.R, Balkwill F.R, and Hynes R.O. (2017) Characterization of the extracellular matrix of normal and diseased tissues using proteomics. Journal of Proteome Research,16(8):3083-3091. [Full Text]

Gocheva V, Naba A*, Bhutkar A, Guardia T, Miller K.M, Li C.M, Dayton T.L, Sanchez-Rivera F.J, Kim-Kiselak C, Jailkhani N, Winslow M.W, Del Rosario A, Hynes R.O, and Jacks T*. (2017)
Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proceedings of the National Academy of Sciences, 114(28):E5625-E5634. [Full Text]

Glavey S.V#, Naba A#, Manier S#, Clauser K.R, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer M.E, Asara J.M, Palumbo A, Roccaro A.M, Hynes R.O, and Ghobrial I.M. (2017) Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. Leukemia [Full Text]

Ragelle H#, Naba A#, Larson B.L, Zhou F, Prijic M, Whittaker C.A, Del Rosario A, Langer R, Hynes R.O, and Anderson D.G. (2017) Comprehensive proteomic characterization of stem-cell-derived extracellular matrices. Biomaterials, 128:147-159. [Full Text]

Naba A*, Clauser K.R, Mani D.R, Carr S.A, and Hynes R.O*. (2017) Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression. Scientific Reports, 7:40495. [Full Text]

Carmona G#, Perera U#, Gillett C, Naba A, Law A.L, Sharma V.P, Wang J, Wyckoff J, Balsamo M, Mosis F, De Piano M, Monypenny J, Woodman N, McConnell R.E, Mouneimne G, Van Hemelrijck M, Cao Y, Condeelis J, Hynes R.O, Gertler F.B, and Krause M. (2016) Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE. Oncogene, 35:5155-69. [Full Text]

Naba A*, Clauser K.R, and Hynes R.O. (2015) Enrichment of extracellular matrix proteins from tissues and digestion into peptides for mass spectrometry analysis. Journal of Visualized Experiments, 101:e53057. [Video] [Full Text]

Naba A*, Clauser K.R, Whittaker C.A, Carr S.A, Tanabe K.K, and Hynes R.O*. (2014b) Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer, 14(1):518. [Full Text]
Received the “Highly Accessed” designation by BMC Cancer
Read the F1000 recommendation of this article.

Naba A*, Clauser K.R, Lamar J.M, Carr S.A and Hynes R.O*. (2014a) Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. eLife, 3:e01308. [Full Text]

Read the F1000 recommendation of this article.
Read the
MIT News coverage

Naba A#, Clauser K.R#, Hoersch S, Liu H, Carr S.A*, and Hynes R.O.* (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Molecular and Cellular Proteomics, 11(4):M111.014647. [Full Text]

Read the F1000 recommendation of this article.

Mak H#, Naba A#, Varma S#, Meens J, Arpin M, SenGupta S, and Elliott B.E. (2012) Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells. BMC Cancer, 12(1):82-95. [Full Text]
Received the “Highly Accessed” designation by BMC Cancer

Zwaenepoel I#, Naba A#, da Cunha M.M.L#, Del Maestro L, Formstecher E, Louvard D, and Arpin M. (2012) Ezrin regulates microvillus morphogenesis by promoting distinct activities of Eps8 proteins. Molecular Biology of the Cell, 23(6):1080-95. Cover [Full Text]

Kanda S, Naba A, and Miyata Y. (2009) Inhibition of endothelial cell chemotaxis toward FGF-2 by Gefitinib associates with downregulation of Fes activity. International Journal of Oncology, 35:1305-1312. [Full Text]

Monni R, Haddaoui L, Naba A, Arpin M, Mayeux P, and Moreau-Gachelin F. (2008) Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia. Blood, 6:3163-3172. [Full Text]

Naba A, Reverdy C, Louvard D, and Arpin M. (2008) Spatial recruitment and activation of the Fes kinase by ezrin promotes HGF-induced cell scattering. EMBO Journal, 27:38-50. [Full Text]

Reviews and book chapters

Socovich AM and Naba A. (2018) The cancer matrisome: from comprehensive characterization to biomarker discovery. Seminars in Cell & Developmental Biology, pii: S1084-9521(17)30580-3. [Full Text]

Zhou Y, Horowitz JC, Naba A, Ambalavanan N, Atabai K, Balestrini J, Bitterman PB, Corley RA, Ding BS, Engler AJ, Hansen KC, Hagood JS, Kheradmand F, Lin QS, Neptune E, Niklason L, Ortiz LA, Parks WC, Tschumperlin DJ, White ES, Chapman HA, Thannickal VJ. (2018) Extracellular matrix in lung development, homeostasis and disease. Matrix Biology, pii: S0945-053X(17)30434-1. [Full Text]

Naba A*, Clauser K.R, Ding H, Whittaker C.A, Carr S.A, and Hynes R.O*. (2016) The extracellular matrix in the “omics” era. Matrix Biology, pii: S0945-053X(15)00121-3. [Full Text]

Naba A, Hoersch S, and Hynes R.O. (2012) Towards Definition of an ECM Parts List: an Advance on GO Categories. Matrix Biology, 31(7/8):371-372. [Full Text]

Hynes R.O and Naba A. (2012) Overview of the Matrisome – an Inventory of ECM Constituents and Functions. In Extracellular Matrix Biology (eds. R.O. Hynes and K.M. Yamada), Cold Spring Harbor Perspectives in Biology, 4(1):a004903. [Full Text]
Read the review of the book "Extracellular Matrix Biology" by Dr. Charles Streuli in Development.

Arpin M, Chirivino D, Naba A, and Zwaenepoel I. (2011) Emerging role for ERM proteins in cell adhesion and migration. Cell Adhesion and Migration, 5:199-206. [Full Text]

#Equal contribution; *Corresponding authors


Cancer-related extracellular matrix signatures and related methods and products. Hynes R.O, Naba A, Carr S.A, Clauser K.R and Tanabe K.K. Issued December 27, 2016 under the U.S. Patent No. 9,526,800.  Divisional application issued July 17, 2018 underthe U.S. Patent No. 10,024,860.